Download Citation
Article Source:
Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects
Dieye TN,
NDiaye BP,
Dieng AB,
Fall M,
Britain N,
et al.
(2013)
Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.
PLOS ONE 8(6): e67177.
https://doi.org/10.1371/journal.pone.0067177